Related by context. All words. (Click for frequent words.) 75 liposomal formulation 75 mertansine 74 Genasense ® oblimersen 74 oral prodrug 73 anticancer agent 73 Genasense R oblimersen 73 proteasome inhibitor 73 Archexin 73 targeted radiotherapeutic 73 vascular disrupting agent 72 PDE4 inhibitor 72 investigational humanized monoclonal antibody 72 mitogen activated ERK kinase 72 Panzem R 72 histone deacetylase HDAC inhibitor 72 AEG# 72 MEK inhibitor 72 FOLOTYN ® 72 Dapagliflozin 72 PROVENGE sipuleucel T 72 IL# PE#QQR 71 highly selective inhibitor 71 huC# DM4 71 Onconase 71 inhaled formulation 71 alkylating agent 71 PHX# 71 IMA# 71 Proxinium TM 71 Xanafide 71 Phase #b/#a clinical 71 tiapamil 71 CEQ# 71 PEG SN# 71 VitiGam 71 orally bioavailable 71 orally administered inhibitor 71 alvespimycin 71 Carfilzomib 71 Phase Ib study 71 HCV protease inhibitor 71 Personalized Immunotherapy 71 generation purine nucleoside 71 PNP inhibitor 71 TRO# 71 seliciclib CYC# 70 PrevOnco ™ 70 sodium Injection 70 Amrubicin 70 phase IIb trial 70 Cloretazine ® 70 EOquin TM 70 targeted antifolate 70 PI3K/Akt pathway inhibitor 70 Cloretazine 70 non nucleoside inhibitor 70 2 methoxyestradiol 70 therapeutic monoclonal antibody 70 pan HDAC inhibitor 70 PSN# [002] 70 histamine dihydrochloride 70 Traficet EN 70 ATL# [002] 70 Azedra 70 JAK2 inhibitor 70 dihydrochloride 70 PDX pralatrexate 70 Annamycin 70 sodium glucose cotransporter 70 Zybrestat 70 virus HCV protease inhibitor 70 histone deacetylase inhibitor 70 drug ISA# 70 GW# [003] 70 Aplidin 70 receptor tyrosine kinase inhibitor 70 investigational pan BCR 70 TBC# 70 Hsp# Inhibitor 69 EOquin 69 LHRH antagonist 69 investigational antiplatelet agent 69 BAY #-# 69 LEP ETU 69 KNS # 69 forodesine 69 TLK# 69 TNF Tumor Necrosis Factor 69 Allovectin 7 69 JAK inhibitor 69 IRX 2 69 radiation sensitizer 69 IgG1 monoclonal antibody 69 entinostat 69 Squalamine 69 Fodosine 69 Phase IIb clinical trials 69 PGL# 69 Curaxin CBLC# 69 Sym# 69 polysaccharide polymer 69 ATL# [001] 69 trastuzumab DM1 T DM1 69 acetonide FA 69 lorvotuzumab mertansine 69 anti amnesic 69 Aflibercept 69 Tyrima 69 Ceflatonin 69 PRT# 69 IAP inhibitors 69 Amplimexon 69 lucinactant 69 RhuDex ® 69 Aviptadil 69 dasatinib Sprycel ® 69 metaglidasen 69 angiogenesis inhibitor 69 Tezampanel 69 Locteron ® 69 AKT inhibitor 69 Quinamed 69 delivers fluocinolone acetonide FA 69 Marqibo TM 69 Panzem R NCD 69 Pathway Inhibitor 69 dextofisopam 69 TG# [003] 69 apricitabine ATC 69 HQK 69 Cetrorelix 69 MEK inhibitor RDEA# 68 erlotinib Tarceva ® 68 Tesetaxel 68 Elagolix 68 novel prodrug 68 Degarelix 68 molecular imaging radiopharmaceutical 68 ALN TTR 68 multi kinase inhibitor 68 depsipeptide 68 vidofludimus 68 YONDELIS R 68 BiovaxID TM 68 phase IIb clinical 68 ocular formulation 68 Irinotecan 68 small molecule Hedgehog 68 leading oral taxane 68 TYSABRI natalizumab 68 HepaSphere 68 signal transduction inhibitor 68 Iluvien ® 68 selective modulator 68 protein kinase inhibitor 68 docetaxel Taxotere R 68 Cleviprex TM clevidipine 68 Intravenous CP 68 CCX# 68 efaproxiral 68 Naproxcinod 68 Troxatyl 68 candidate AP# 68 somatostatin analogue 68 TPI ASM8 68 Vaprisol 68 Tanespimycin 68 OncoGel 68 oral salmon calcitonin 68 JAK1 68 PLK1 SNALP 68 cutaneous T 68 Tarceva TM 68 Solazed TM 68 obatoclax 68 Kamada AAT 68 compound AEZS 68 fosbretabulin 68 IMiDs R 68 SAR# [004] 68 lomitapide 68 Safinamide 68 candidate deforolimus 68 SPL# Gel vaginal microbicide 68 chimeric monoclonal antibody 68 generation Hsp# inhibitor 68 Dasatinib 68 Vicinium TM 68 drug GAP #B# 68 Cannabinor 68 MAGE A3 ASCI 68 PEGylated anti 68 AP# [003] 68 intranasal formulation 68 oral ridaforolimus 68 Onco TCS 68 ulimorelin 68 antibody MAb 68 acyclovir Lauriad R 68 ZOLINZA 68 Alocrest 68 reslizumab 68 Panzem 68 Orally administered 68 Seliciclib 68 cathepsin K inhibitor 68 sorafenib Nexavar 68 lapatinib Tykerb 68 YONDELIS 68 Pegloticase 68 phase IIa clinical 68 Elvitegravir 68 elotuzumab 68 vascular disrupting agents 68 ONCONASE R 68 Bicifadine 67 ADP receptor antagonist 67 ongoing Phase 1b 67 docetaxel Taxotere ® 67 subcutaneous formulation 67 long acting muscarinic 67 Nanobody 67 Factor VIIa 67 Atiprimod 67 XmAb# 67 DXL# 67 ZEVALIN ® 67 Perifosine 67 Liprotamase 67 Qutenza TM 67 radiotherapeutic 67 AAG geldanamycin analog 67 investigational pharmacologically unique 67 Tarvacin TM 67 Mipomersen 67 HuMax CD4 67 CAPHOSOL R 67 TH# [003] 67 HuMax EGFr 67 gefitinib Iressa 67 CYT# potent vascular disrupting 67 Phase #b/#a trial 67 Nexavar sorafenib 67 MEK inhibitors 67 neratinib 67 CR# vcMMAE 67 ATL/TV# 67 mGluR5 negative 67 hyaluronidase enzyme 67 RLY# 67 USL# 67 XL# XL# 67 glucokinase activator 67 Aganocide 67 Spiegelmer ® 67 IAP inhibitor 67 selective kinase inhibitor 67 compound perifosine 67 Ceflatonin R 67 Exherin TM 67 PrevOnco 67 isoform selective 67 Voreloxin 67 novel histone deacetylase 67 OMNARIS HFA 67 octreotide implant 67 Triapine 67 ospemifene 67 ProLindac TM 67 CCR9 antagonist 67 Aganocide ® 67 Silodosin 67 ThermoDox R 67 Preclinical studies suggest 67 peripherally acting 67 dasatinib Sprycel 67 Alzhemed TM 67 PSMA ADC 67 ALN PCS 67 LymphoStat B TM 67 OMP #M# 67 RNAi therapeutic targeting 67 Bortezomib 67 SinuNase TM 67 cetuximab Erbitux 67 OvaRex ® MAb 67 Ridaforolimus 67 PANVAC VF 67 hormone LHRH antagonist 67 Pralatrexate 67 INCB# [001] 67 candidate ridaforolimus 67 Onalta ™ 67 CINOD 67 P#X# antagonist 67 ALN TTR# 67 regorafenib 67 torezolid phosphate 67 compound INCB# 67 candidate CRLX# 67 teduglutide 67 androgen receptor antagonist 67 ALK inhibitor 67 CYC# 67 Aplidin R 67 Radezolid 67 nucleoside analog 67 Cand5 67 volociximab 67 Vidaza azacitidine 67 Afatinib 67 methylnaltrexone bromide 67 Onrigin 67 LibiGel ® 67 hormone agonist 67 AQ4N 67 Talabostat 67 SinuNase ™ 67 BrachySil TM 67 Aptocine 67 pharmacokinetic PK study 67 bortezomib Velcade 67 inhaled AAT 67 Nexavar ® 67 SIR Spheres 67 rxRNA 66 PSN# [001] 66 CINTREDEKIN BESUDOTOX 66 OHR/AVR# 66 modulator SERM 66 TKB# 66 epothilone 66 mTOR inhibitor 66 CBLC# 66 VNP#M 66 novel VDA molecule 66 gallium containing 66 5 HT3 antagonist 66 HDACi 66 Velcade bortezomib 66 OvaRex R 66 oral picoplatin 66 MGCD# [001] 66 anti angiogenic agent 66 NVA# 66 antisense oligonucleotide 66 XYOTAX TM 66 BEMA Granisetron 66 MNTX 66 corticosteroid dexamethasone 66 ARRY # 66 IMiDs ® 66 CCR5 antagonist 66 PKC# 66 Hsp# inhibitor 66 protein tyrosine phosphatase 1B 66 Ambrisentan 66 selective adenosine 66 NeuVax 66 Sapacitabine 66 HGS# 66 vinca alkaloid 66 PEGylated interferon 66 pseudobulbar affect PBA 66 Fx #A 66 PI3K inhibitor 66 Pirfenidone 66 Exherin 66 MKC# MT 66 hypoxia selective 66 sorafenib tablets 66 targets Galectin receptors 66 RELOVAIR ™ 66 refractory chronic lymphocytic 66 HCV NS5B polymerase 66 HyACT 66 luteinizing hormone releasing 66 tezampanel 66 Phase Ib II 66 lexidronam injection 66 Plicera 66 R#/MEM # 66 eniluracil 66 imatinib Gleevec ® 66 liprotamase 66 CDP# 66 Tarmogen 66 VAPRISOL 66 Onalta 66 Phase Ib clinical trials 66 registrational trial 66 ENMD # 66 personalized cellular immunotherapy 66 oral proteasome inhibitor 66 systemically administered 66 Denufosol 66 Nexavar sorafenib tablets 66 topically applied SEPA 66 HuLuc# 66 XL# anticancer compounds 66 DB# [003] 66 Muraglitazar 66 EcoNail 66 ORE# 66 CRMD# 66 CTAP# Capsules 66 Anavex #-# 66 Angiocept 66 SNT MC# 66 trastuzumab Herceptin 66 rALLy clinical trial 66 thalidomide Thalomid 66 metastatic hormone refractory 66 Phase 2b clinical trials 66 ABL inhibitor 66 investigational compound 66 evaluating tivozanib 66 ARIKACE ™ 66 Interferon alpha 66 gallium nitrate injection 66 DAVANAT R 66 Myocet 66 Junovan TM 66 deforolimus 66 thymalfasin 66 sulodexide 66 bucindolol hydrochloride 66 ISTODAX 66 novel oral anticoagulant 66 OncoVEX GM CSF 66 AMPA kainate 66 Eniluracil 66 ELACYT 66 beta 1a 66 pralatrexate 66 immunosuppressive compound 66 Methylnaltrexone 66 polymerase inhibitor 66 PEGylated Fab fragment 66 small molecule tyrosine 66 Civacir 66 ATPace TM 66 GRN# 66 HER2 positive metastatic breast 66 #D#C# 66 drug pipeline TAFA# 66 QuadraSphere 66 Friedreich Ataxia FRDA 66 severe gastroparesis 66 LibiGel transdermal testosterone gel 66 RGB # 66 Zorbtive TM 66 Gleevec imatinib mesylate 66 Intravenous Human 66 Zolinza 66 ZK EPO 66 Azedra TM 66 relapsed leukemia 66 orally dosed 66 darinaparsin ZIO 66 farletuzumab 66 SAR# [002] 66 investigational oral 66 selective androgen receptor modulator 66 selective agonist 66 Cloretazine R 66 Genasense ® 66 Clolar ® 66 indibulin 66 candidate Zenvia 66 hypoxia activated prodrug 66 ruxolitinib 66 talabostat 66 monoclonal antibody conjugated 66 BAL# [002] 66 Virulizin ® 66 alefacept 66 sodium thiosulfate STS 66 selective immunoproteasome inhibitor 66 proprietary polysaccharide 66 immunotherapeutic agent 66 nucleoside reverse transcriptase inhibitor 66 Lodotra TM 66 prostone 66 peptidomimetic 66 vorinostat 66 Pertuzumab 66 BCR ABL inhibitor 66 NeuroSTAT ® 66 gastrointestinal stromal tumors GIST 66 Omacetaxine 66 PORxin TM 66 2 inhibitor CYT# 66 MKC# MKC# PP 66 selective antagonist 66 phase IIb study 65 Maribavir 65 novel peptide 65 tubulin inhibitor 65 GLP1 INT TM 65 Tocosol Paclitaxel 65 ALN VSP 65 AA amyloidosis 65 cell lymphoma CTCL 65 Diamyd ® 65 Pafuramidine 65 Neo Urinary Conduit 65 Proellex TM 65 Guanilib 65 Menadione 65 mesylate 65 Blinatumomab 65 autologous cellular immunotherapy 65 novel anticancer 65 REG1 Anticoagulation System 65 perifosine KRX 65 LymphoStat B belimumab 65 topically administered 65 Ozarelix 65 oral anticancer 65 Telatinib 65 Zysolin TM 65 mTOR mammalian target 65 methylnaltrexone 65 compound PMX # 65 oxybutynin gel 65 microtubule inhibitor 65 MEK Inhibitor 65 Teysuno 65 solithromycin 65 Tolvaptan 65 PI3 kinase inhibitors 65 vosaroxin 65 Mepact 65 vinorelbine tartrate 65 cetuximab Erbitux R 65 proteasome inhibitors 65 Enzastaurin 65 Diamyd R 65 afamelanotide 65 Zemiva TM 65 Zenvia ™ 65 LE SN# 65 Factor Xa inhibitor 65 Anturol ® 65 R roscovitine 65 ALV# 65 paclitaxel Taxol 65 Akt inhibitor 65 TELINTRA 65 NUEDEXTA ™ 65 rNAPc2 65 Evoltra ® 65 EcoNail TM 65 Modrenal R 65 orally inhaled 65 JZP 65 cysteamine bitartrate 65 Enzyme Replacement Therapy 65 relapsed refractory multiple myeloma 65 tumor vascular disrupting 65 Daclizumab 65 malignant ascites 65 MGd 65 Dyloject TM 65 cetuximab Erbitux ® 65 PEP# [003] 65 VALSTAR 65 CRLX# 65 humanized monoclonal 65 EndoTAG TM -1 65 CDK inhibitor 65 Alexza Staccato 65 Prodarsan ® 65 Dacogen decitabine 65 enzastaurin 65 ILUVIEN ® 65 midstage trials 65 cleavable linker 65 Gamunex C 65 PRTX 65 Initiates Enrollment 65 dalbavancin 65 nilotinib Tasigna ® 65 Temsirolimus 65 essential thrombocythemia ET 65 Cethrin R 65 EGS# 65 CORT # 65 huN# DM1 65 Vidaza R 65 secondary hyperparathyroidism 65 therapeutic monoclonal antibodies 65 SERMs 65 zanolimumab 65 TEMODAL 65 pan histone deacetylase 65 LY# [003] 65 BrachySil 65 Darinaparsin 65 CIMZIA ™ 65 Vandetanib 65 TKM ApoB 65 Ixempra 65 refractory gout 65 NOX E# 65 MOVIPREP R 65 BLP# Liposome Vaccine 65 Zalypsis 65 HDAC Inhibitor 65 Inhalation Aerosol 65 Aurora kinase inhibitor 65 elacytarabine 65 Insegia 65 investigational monoclonal antibody 65 Androxal TM 65 Bazedoxifene 65 eprotirome 65 brivanib 65 TOCOSOL Camptothecin 65 intravenously administered 65 BN# [002] 65 homotaurine 65 topical ophthalmic 65 Oral NKTR 65 IMC #B 65 tanespimycin 65 compound AEOL # 65 selective inhibition 65 Pivotal Phase III 65 allosteric modulator 65 TACI Ig 65 ganetespib 65 CB2 selective receptor agonist 65 Plenaxis TM 65 BXT # 65 Phase 2a clinical 65 immunotherapeutic vaccine 65 DP b# 65 GAP #B# 65 Cyclooxygenase Inhibiting Nitric Oxide 65 Sanvar R 65 bortezomib Velcade ® 65 Evoltra 65 Aurexis 65 Deforolimus 65 bardoxolone 65 bevacizumab Avastin ® 65 diarrhea predominant irritable 65 E2F Decoy 65 GLP toxicology studies 65 TRX1 65 Gemzar ® 65 candidates bavituximab 65 romidepsin 65 Cetuximab Erbitux 65 CA4P 65 kidney urologic 65 oral taxane 65 #ME# 65 anti CD3 antibody 65 TAFA# 65 HSP# inhibitor 65 RAV# 65 #I TM# 65 Resten NG 65 sapacitabine CYC# 65 Icatibant 65 Orathecin 65 Symadex 65 torezolid 65 renin inhibitors 65 mesylate tablets 65 Anturol TM 65 Panzem NCD 65 Oracea TM 65 Phase IIa trials 65 ApoB SNALP 65 allosteric modulator NAM 65 BRIM2 65 Davanat 65 small molecule thrombopoietin 65 Zingo TM 65 Initiates Phase II 65 Genz # 65 IMC A# 65 chemopreventive agent 65 Chemophase 65 orally bioavailable mimics 65 HCD# [002] 65 HCV protease inhibitors 65 Trodusquemine 65 amrubicin 65 VivaGel ™ 65 GAMMAGARD 65 NXL# 65 protein mTOR 65 telomerase therapeutic 65 Xyfid TM 65 Sudhir Agrawal D.Phil 65 HuMax 65 IND submission 65 aleglitazar 65 axitinib 65 ELND# 65 Fibrillex TM 65 Alpharadin 64 Cintredekin Besudotox 64 EndoTAG 64 SPRYCEL ® 64 Familial Adenomatous Polyposis FAP 64 Alvesco R 64 Troxatyl TM 64 Cloretazine VNP#M 64 CD3 monoclonal antibody 64 transdermal spray 64 Bicalutamide 64 otelixizumab 64 PNT# 64 Tasimelteon 64 Enkephalin 64 RIGScan CR 64 inhibitor PPI 64 Microspheres 64 OXi# 64 Survivin antagonist 64 Inhalation Solution 64 DPX Survivac 64 inhaled liposomal ciprofloxacin 64 sulfonylhydrazine class 64 Aurora Kinase 64 metastatic malignant 64 Reverset 64 acadesine 64 Phase 2a trial 64 adenosine injection 64 glucagon receptor 64 siRNA therapeutic 64 investigational hepatitis C 64 Orazol 64 LAF# 64 alpha folate receptor 64 Octreotide 64 Ferumoxytol 64 selective orally bioavailable 64 IV Busulfex 64 INCB# [003] 64 candidate TNFerade biologic 64 oral ghrelin agonist 64 xanthine oxidase inhibitor 64 Tumour Vascular Disrupting Agent 64 Luteinizing Hormone Releasing Hormone 64 Abiraterone acetate 64 candidate XP# 64 TLR9 agonist 64 DNA intercalator 64 paclitaxel Taxol ® 64 lumiliximab 64 Thiarabine 64 pitavastatin 64 RNA antagonist 64 Opterone R 64 AZILECT R 64 OncoVex 64 GVAX ® 64 biologic therapy 64 enzyme inhibitor 64 HCV protease 64 Vascular Disrupting Agent 64 ZADAXIN ® 64 Iluvien TM 64 Pimavanserin 64 erlotinib Tarceva 64 oxybutynin ATD TM 64 herpetic keratitis 64 radezolid 64 anticancer compounds 64 Ostabolin C TM 64 MyVax R 64 ISIS # 64 UPLYSO 64 Pemetrexed 64 Argatroban 64 including eniluracil ADH 64 tafamidis 64 Vascugel 64 oral gallium 64 HuMax TAC 64 CDK cyclin dependent 64 Pyridorin 64 Cloretazine R VNP#M 64 Glufosfamide 64 registrational 64 BEMA TM LA 64 intravesical instillation 64 MKC# 64 delta opioid receptor 64 SCH # 64 sunitinib malate 64 cannabinor 64 Ophthotech 64 selective inhibitor 64 oral dual endothelin 64 oral rivaroxaban 64 Phase Ib clinical 64 Phenoptin 64 Bezielle 64 superficial bladder cancer 64 paclitaxel Taxol R 64 modified glutathione analog 64 ELND-#/AZD-# 64 PF # [002] 64 LEUKINE 64 FUSILEV ® 64 TOCOSOL Paclitaxel 64 Liposomal 64 Polymer Microspheres 64 estradiol transdermal spray 64 Phase IIb trials 64 Veregen TM 64 rifalazil 64 omacetaxine mepesuccinate 64 sargramostim 64 faropenem medoxomil 64 COX Inhibiting Nitric Oxide 64 mGluR5 NAM 64 DNA RNA Medicines 64 cMET 64 immunotoxin 64 ZACTIMA 64 octreotide acetate 64 phase Ib clinical 64 metastatic castration resistant 64 investigational HCV polymerase 64 tolevamer 64 Campath ® 64 Veronate 64 Radiation Therapy SIRT 64 romazarit 64 Initiates Clinical 64 candidate Gencaro TM 64 Imatinib mesylate 64 Ophena TM 64 synthetic retinoid 64 Ceplene TM 64 Phase #/#a trial 64 romidepsin novel 64 DU #b 64 Deferiprone 64 Angiolix 64 investigational immunotherapy 64 ESBA# 64 MAP# 64 M2 subunit 64 RNAi Therapeutic 64 tramiprosate 64 injectable formulation 64 pertuzumab 64 Lisofylline LSF 64 humanized monoclonal antibody 64 Menerba 64 StemEx 64 cangrelor 64 ALK inhibitors 64 BCR ABL inhibitors 64 systemic RNAi therapeutic 64 tyrosine kinase inhibitor 64 ponatinib 64 Phase III Clinical Trial 64 thetreatment 64 Xcytrin R 64 INCB# [002] 64 arsenic trioxide injection 64 inhalation powder 64 Piperacillin 64 anti CD3 monoclonal 64 Oral Spray 64 THR beta agonist 64 Aurora kinase 64 Indaflex TM 64 HCV polymerase inhibitors 64 luliconazole 64 DPP4 inhibitor 64 Targretin 64 Cotara R 64 HGS ETR1 64 IMiD 64 diclofenac sodium 64 highly selective endothelin 64 antibody MT# 64 personalized immunotherapy 64 demonstrated antitumor activity 64 HGS ETR2 64 Lixivaptan 64 GED aPC 64 histone deacetylase HDAC 64 Alfimeprase 64 BioNumerik 64 Lubiprostone 64 denileukin diftitox 64 RECOTHROM R 64 Zenpep 64 MT#/MEDI-# 64 PEGPH# 64 phase III isavuconazole 64 Clofarabine 64 immatics 64 Ciclesonide 64 Phase #b/#a 64 lintuzumab SGN 64 GMX# 64 AzaSite Xtra 64 Romidepsin 64 Emezine 64 HuMax CD# 64 non nucleoside 64 diabetic neuropathic pain 64 Laquinimod 64 evaluating satraplatin 64 novel immunomodulatory 64 chemotherapy induced neutropenia 64 Angiotensin Converting Enzyme 64 StemEx R 64 trastuzumab Herceptin ® 64 Gleevec resistant 64 A3 adenosine receptor 64 refractory cutaneous T 64 Pazopanib 64 Zavesca R 64 Rebif ® 64 triphendiol 64 neuroprotective properties 64 Inc. AMEX YMI 64 Elotuzumab 64 investigational protease inhibitor 64 Initiates Phase III 64 cancer immunotherapies 64 product Fentanyl TAIFUN 64 Hepatocellular Carcinoma HCC 64 Vidofludimus 64 hPTH #-# 64 itraconazole Sporanox 64 Litx 64 G#DT 64 Saxagliptin 64 VitiGam TM 64 Bremelanotide 64 multicenter Phase II 64 systemic anaplastic large 64 Completes Patient Enrollment 64 varespladib 64 PCK# 64 JAK inhibitors 64 Phase 1a clinical 64 Ganciclovir 64 agent bevasiranib 64 PREOS R 64 oxaliplatin Eloxatin 64 HyperAcute 64 generation proteasome inhibitor 64 CAPHOSOL 64 CVac 64 Chemokine Therapeutics 64 Urocidin 64 TOCOSOL 64 BNC# 64 Dalbavancin 64 Solulin 64 Onalta TM 64 irreversible inhibitor 64 metastatic castrate resistant 64 Soliris eculizumab 64 atrasentan 64 topical formulations 64 sulindac 64 postoperative ileus 64 SUCCEED trial 64 Fludara ® 64 darinaparsin 64 ATIR 64 Announces Poster Presentations 64 RhuDex R 64 polymerase inhibitors 64 OncoVEX 64 Vilazodone 64 daptomycin 63 nanopharmaceutical 63 Anticalin R 63 Junovan 63 vivo validation 63 Zarnestra 63 chemically modified siRNA 63 QRxPharma 63 bendamustine HCl 63 Presents Preclinical 63 REG1 63 metastatic colorectal 63 Taxotere docetaxel 63 RANK Ligand inhibitor